Introduction HIV incidence is high during pregnancy and breastfeeding with HIV acquisition
risk more than doubling during pregnancy and the postpartum period compared to when …

The effectiveness of HIV pre-exposure prophylaxis (PrEP) hinges on adherence, which has
been restricted by multifaceted barriers. Uptake of PrEP has been impeded by poor access …

Introduction: Stigma and disclosure concerns have been key barriers to oral pre-exposure
prophylaxis (PrEP) adherence for African adolescent girls and young women (AGYW) in …

Background Pregnant women in settings with high HIV prevalence are at increased risk of
HIV acquisition and subsequent vertical transmission. We implemented and evaluated a …

Prior to widespread availability of antiretroviral therapy (ART) in sub-Saharan Africa,
children who were HIV-exposed but uninfected (HEU) had increased mortality, morbidity …

Background Strengthening HIV prevention is imperative given the continued high HIV
incidence worldwide. The introduction of oral PrEP as a new biomedical HIV prevention tool …

Background Intracellular tenofovir diphosphate (TFV-DP) concentration in dried blood spots
(DBSs) is used to monitor cumulative pre-exposure prophylaxis (PrEP) adherence. We …

Background Pre-exposure prophylaxis (PrEP) is an emerging biomedical prevention
intervention. Documenting PrEP service delivery models (SDMs) that promote linkage to and …

Background: Discontinuation of daily oral pre-exposure prophylaxis (PrEP) is frequent
among adolescent girls and young women (AGYW) in African settings. We explored factors …

Pregnancy is a high-risk period for HIV acquisition in African women, and pregnant women
who become acutely infected with HIV account for up to a third of vertical HIV transmission …